| 1 | T-Cell Lymphoma | 48.9% |
| 2 | Mantle cell lymphoma | 48.9% |
| 3 | Sezary Syndrome | 37.1% |
| 4 | Lymphoma, T-Cell, Cutaneous | 36.5% |
| 5 | Lymphoma, AIDS-Related | 36.5% |
| 6 | Enteropathy-Associated T-Cell Lymphoma | 36.5% |
| 7 | Primary Effusion Lymphoma | 36.5% |
| 8 | Hodgkin Disease | 35.5% |
| 9 | Composite Lymphoma | 34.7% |
| 10 | Lymphomatoid Granulomatosis | 34.1% |
| 11 | Mycosis Fungoides | 30.3% |
| 12 | Lymphomatoid Papulosis | 30.3% |
| 13 | Plasmablastic lymphoma | 30.3% |
| 14 | Burkitt Lymphoma | 27.6% |
| 15 | Tumor Lysis Syndrome | 22.7% |
| 16 | Autoimmune Lymphoproliferative Syndrome | 18.8% |
| 17 | Lymphoma, Extranodal NK-T-Cell | 17.9% |
| 18 | Infectious Mononucleosis | 17.4% |
| 19 | Plasmacytoma | 17.2% |
| 20 | Primary amyloidosis | 15.8% |
| 21 | Lymphangioleiomyomatosis | 15.1% |
| 22 | Histiocytic Disorders, Malignant | 14.8% |
| 23 | Leukemia, T-Cell | 14.4% |
| 24 | Leukemia, B-Cell | 14.4% |
| 25 | Heavy Chain Disease | 14.3% |
| 26 | Sarcoidosis | 14.1% |
| 27 | Leukemia, Plasma Cell | 13.7% |
| 28 | Agammaglobulinemia | 13.5% |
| 29 | Waldenstrom Macroglobulinemia | 13.4% |
| 30 | Multiple Myeloma | 13.4% |
| 31 | Lymphocele | 12.3% |
| 32 | leukemia | 12.3% |
| 33 | Neoplasms, Germ Cell and Embryonal | 12.3% |
| 34 | Neoplasms, Glandular and Epithelial | 12.3% |
| 35 | Germ Cell Cancer | 12.3% |
| 36 | Neuroectodermal Tumors | 11.7% |
| 37 | Granuloma | 11.5% |
| 38 | Neoplasms, Neuroepithelial | 11.3% |
| 39 | Gliomatosis cerebri | 11.3% |
| 40 | Adenitis | 11.1% |
| 41 | Histiocytosis | 11.1% |
| 42 | Lymphadenitis | 11.1% |
| 43 | Lymphangitis | 11.1% |
| 44 | Lymphedema | 11.1% |
| 45 | Splenic Diseases | 11.1% |
| 46 | Thymus Hyperplasia | 11.1% |
| 47 | Pseudolymphoma | 11.1% |
| 48 | Lymphadenopathy | 11.1% |
| 49 | Thymus Neoplasms | 10.9% |
| 50 | Paraproteinemias | 10.5% |
| 51 | Thymoma | 10% |
| 52 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 9.8% |
| 53 | Leukemia, Large Granular Lymphocytic | 9.8% |
| 54 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 9.8% |
| 55 | Carcinosarcoma | 9.7% |
| 56 | Hemangiosarcoma | 9.7% |
| 57 | lymphangiosarcoma | 9.7% |
| 58 | melanoma | 9.6% |
| 59 | Meningioma | 9% |
| 60 | Lymphatic Abnormalities | 9% |
| 61 | Transfusion Reaction | 8.9% |
| 62 | Hypotensive Transfusion Reaction | 8.9% |
| 63 | Hypergammaglobulinemia | 8.9% |
| 64 | Malignant histiocytosis | 8.7% |
| 65 | Histiocytic sarcoma | 8.7% |
| 66 | Medulloblastoma | 8.5% |
| 67 | Carcinoma 256, Walker | 8.4% |
| 68 | Monoclonal Gammopathy of Undetermined Significance | 8.3% |
| 69 | Splenic Neoplasms | 8.2% |
| 70 | Lymphangiectasis, Intestinal | 8.2% |
| 71 | Adenoma, Acidophil | 8% |
| 72 | Ganglioneuroma | 8% |
| 73 | Glioma | 8% |
| 74 | Malignant Glioma | 8% |
| 75 | Basal cell carcinoma | 7.7% |
| 76 | Carcinoma, Papillary | 7.7% |
| 77 | Squamous cell carcinoma | 7.7% |
| 78 | Chondrosarcoma | 7.7% |
| 79 | Craniopharyngioma | 7.7% |
| 80 | Cystadenoma | 7.7% |
| 81 | leiomyosarcoma | 7.7% |
| 82 | liposarcoma | 7.7% |
| 83 | Mesothelioma | 7.7% |
| 84 | synovial sarcoma | 7.7% |
| 85 | Trophoblastic Neoplasms | 7.7% |
| 86 | Neuroectodermal Tumor, Melanotic | 7.7% |
| 87 | Angiomyolipoma | 7.7% |
| 88 | Clear Cell Sarcoma of Soft Tissue | 7.7% |
| 89 | Alveolar Soft Part Sarcoma | 7.7% |
| 90 | Neuroendocrine Tumors | 7.7% |
| 91 | Sarcoma, Myeloid | 7.7% |
| 92 | Carcinoma, Basal Cell | 7.7% |
| 93 | Leukemia, Experimental | 7.7% |
| 94 | Hamartoma | 7.6% |
| 95 | Neoplasms, Hormone-Dependent | 7.6% |
| 96 | Neoplasms, Multiple Primary | 7.6% |
| 97 | Paraneoplastic Syndromes | 7.6% |
| 98 | Precancerous Conditions | 7.6% |
| 99 | Neoplasms, Second Primary | 7.6% |
| 100 | Melanoma, Experimental | 7.5% |
| 101 | Mucocutaneous Lymph Node Syndrome | 7.4% |
| 102 | Adenoma | 7.3% |
| 103 | Ameloblastoma | 7.3% |
| 104 | Angiokeratoma | 7.3% |
| 105 | Carcinoma | 7.3% |
| 106 | Chordoma | 7.3% |
| 107 | Hemangioma | 7.3% |
| 108 | hemangiopericytoma | 7.3% |
| 109 | Lymphangioma | 7.3% |
| 110 | Mesenchymoma | 7.3% |
| 111 | Nevus | 7.3% |
| 112 | Teratoma | 7.3% |
| 113 | Hepatoblastoma | 7.3% |
| 114 | Mixed Tumor, Mullerian | 7.3% |
| 115 | Germinoma | 7.3% |
| 116 | Teratocarcinoma | 7.3% |
| 117 | Angiofibroma | 7.3% |
| 118 | Sarcoma | 7.3% |
| 119 | Epithelioma | 7.3% |
| 120 | Autoimmune Diseases | 7.2% |
| 121 | Hypersensitivity | 7.2% |
| 122 | Immunologic Deficiency Syndromes | 7.2% |
| 123 | Immune reconstitution syndrome | 7.2% |
| 124 | Immune Reconstitution Inflammatory Syndrome | 7.2% |
| 125 | Carcinoma, Ehrlich Tumor | 7.2% |
| 126 | Dermoid Cyst | 7.2% |
| 127 | Carcinoma, Lewis Lung | 7.2% |
| 128 | Carcinoid Tumor | 7.2% |
| 129 | Neurilemmoma | 7.2% |
| 130 | Hutchinson's Melanotic Freckle | 7.2% |
| 131 | Melanoma, Amelanotic | 7.2% |
| 132 | Sarcoidosis, Pulmonary | 6.8% |
| 133 | Cystadenocarcinoma | 6.7% |
| 134 | Fibrosarcoma | 6.7% |
| 135 | Osteosarcoma | 6.7% |
| 136 | Mucoepidermoid Carcinoma | 6.7% |
| 137 | Leukemia, Radiation-Induced | 6.6% |
| 138 | Astrocytoma | 6.3% |
| 139 | Ependymoma | 6.3% |
| 140 | oligodendroglioma | 6.3% |
| 141 | Ganglioglioma | 6.3% |
| 142 | gliosarcoma | 6.3% |
| 143 | Anaplastic astrocytoma | 6.3% |
| 144 | Anaplastic Oligodendroglioma | 6.3% |
| 145 | Hematologic Neoplasms | 6.3% |
| 146 | Adenofibroma | 6.2% |
| 147 | Fibroadenoma | 6.2% |
| 148 | Malignant Fibrous Histiocytoma | 6.2% |
| 149 | Choriocarcinoma | 6.2% |
| 150 | Carcinoma, Lobular | 6.2% |
| 151 | Cyst | 6.2% |
| 152 | Neoplastic Processes | 6.2% |
| 153 | Neoplastic Syndromes, Hereditary | 6.2% |
| 154 | Pregnancy Complications, Neoplastic | 6.2% |
| 155 | Endometrial Stromal Sarcoma | 6.2% |
| 156 | Neoplasms, Experimental | 6.1% |
| 157 | Elephantiasis | 6% |
| 158 | Hypersplenism | 6% |
| 159 | Elephantiasis Nostras Verrucosa | 6% |
| 160 | Sarcoma, Experimental | 6% |
| 161 | Malignant Carcinoid Syndrome | 5.9% |
| 162 | Leukemia L1210 | 5.8% |
| 163 | Leukemia P388 | 5.8% |
| 164 | Acanthoma | 5.8% |
| 165 | Bowen's Disease | 5.7% |
| 166 | Paraganglioma | 5.7% |
| 167 | Rhabdomyosarcoma | 5.7% |
| 168 | Giant Cell Tumor of Bone | 5.7% |
| 169 | Glioblastoma | 5.5% |
| 170 | Neuroblastoma | 5.5% |
| 171 | Glioblastoma Multiforme | 5.5% |
| 172 | Retinoblastoma | 5.5% |
| 173 | Multiple Endocrine Neoplasia | 5.5% |
| 174 | Dermatofibrosarcoma | 5.2% |
| 175 | Dermatofibrosarcoma Protuberans | 5.2% |
| 176 | Ganglioneuroblastoma | 5.1% |
| 177 | Neoplasms, Radiation-Induced | 5.1% |
| 178 | Neurofibrosarcoma | 5.1% |
| 179 | Splenic Infarction | 4.9% |
| 180 | Histiocytosis, Langerhans-Cell | 4.9% |
| 181 | Cryoglobulinemia | 4.9% |
| 182 | Sarcoma 180 | 4.8% |
| 183 | Leukemia, Myelomonocytic, Chronic | 4.8% |
| 184 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4.8% |
| 185 | Adenocarcinoma | 4.8% |
| 186 | Carcinoma in Situ | 4.8% |
| 187 | Carcinoma, Transitional Cell | 4.8% |
| 188 | Phyllodes Tumor | 4.8% |
| 189 | Dysgerminoma | 4.8% |
| 190 | Hemangioendothelioma | 4.8% |
| 191 | Lipoma | 4.8% |
| 192 | Myoma | 4.8% |
| 193 | Myxoma | 4.8% |
| 194 | Neuroma | 4.8% |
| 195 | Papilloma | 4.8% |
| 196 | Pseudomyxoma Peritonei | 4.8% |
| 197 | Seminoma | 4.8% |
| 198 | Papillomatosis | 4.8% |
| 199 | Angiolipoma | 4.8% |
| 200 | Myelolipoma | 4.8% |
| 201 | Neoplasms, Bone Tissue | 4.8% |
| 202 | Neoplasms, Fibrous Tissue | 4.8% |
| 203 | Smooth Muscle Tumor | 4.8% |
| 204 | Adenomatosis, Pulmonary | 4.8% |
| 205 | Adenomatous Polyps | 4.8% |
| 206 | Carcinoma, Large Cell | 4.8% |
| 207 | Carcinoma, Small Cell | 4.8% |
| 208 | Desmoplastic Small Round Cell Tumor | 4.8% |
| 209 | Chondroma | 4.8% |
| 210 | Enchondroma | 4.8% |
| 211 | Pheochromocytoma | 4.8% |
| 212 | Alveolar rhabdomyosarcoma | 4.8% |
| 213 | Glomerulonephritis, Membranoproliferative | 4.7% |
| 214 | Carcinoid Heart Disease | 4.7% |
| 215 | Mastocytosis | 4.6% |
| 216 | Nephroblastoma | 4.6% |
| 217 | Thrombocytopenic purpura | 4.5% |
| 218 | Paraneoplastic Encephalomyelitis | 4.4% |
| 219 | Mammary Neoplasms, Experimental | 4.4% |
| 220 | Bone Marrow Neoplasms | 4.3% |
| 221 | Autoimmune thrombocytopenia | 4.3% |
| 222 | Immune thrombocytopenic purpura | 4.3% |
| 223 | Basal Cell Nevus Syndrome | 4.2% |
| 224 | Tuberous Sclerosis | 4.2% |
| 225 | Splenic Rupture | 4.2% |
| 226 | POEMS Syndrome | 4.2% |
| 227 | Abdominal Neoplasms | 4.1% |
| 228 | Erythroplasia | 4.1% |
| 229 | Follicular cyst | 4.1% |
| 230 | Head and Neck Neoplasms | 4.1% |
| 231 | Mucocele | 4.1% |
| 232 | Pilonidal Cyst | 4.1% |
| 233 | Soft Tissue Neoplasms | 4.1% |
| 234 | Thoracic Neoplasms | 4.1% |
| 235 | Thyroglossal Cyst | 4.1% |
| 236 | Synovial Cyst | 4.1% |
| 237 | Aberrant Crypt Foci | 4.1% |
| 238 | Disseminated Intravascular Coagulation | 4.1% |
| 239 | Protein S Deficiency | 4.1% |
| 240 | Hemangioma, Cavernous | 4% |
| 241 | Acoustic Neuroma | 4% |
| 242 | Carcinoma, Pancreatic Ductal | 4% |
| 243 | Lymphopenia | 3.9% |
| 244 | Mastocytosis, Systemic | 3.8% |
| 245 | Transfusion-Related Acute Lung Injury | 3.8% |
| 246 | Mesoblastic Nephroma | 3.7% |
| 247 | Hepatocellular Adenoma | 3.7% |
| 248 | Anemia | 3.7% |
| 249 | Blood Coagulation Disorders | 3.7% |
| 250 | Blood Platelet Disorders | 3.7% |
| 251 | Bone Marrow Diseases | 3.7% |
| 252 | Hemorrhagic Disorders | 3.7% |
| 253 | Immune Complex Diseases | 3.7% |
| 254 | Leukocyte Disorders | 3.7% |
| 255 | Methemoglobinemia | 3.7% |
| 256 | Pancytopenia | 3.7% |
| 257 | Polycythemia | 3.7% |
| 258 | Sulfhemoglobinemia | 3.7% |
| 259 | Antiphospholipid Syndrome | 3.7% |
| 260 | Thrombophilia | 3.7% |
| 261 | Latex allergy | 3.7% |
| 262 | Erythrocytosis | 3.7% |
| 263 | Optic Nerve Glioma | 3.6% |
| 264 | Lymphohistiocytosis, Hemophagocytic | 3.6% |
| 265 | Schnitzler Syndrome | 3.6% |
| 266 | Erdheim-Chester Disease | 3.6% |
| 267 | Adenoid Cystic Carcinoma | 3.6% |
| 268 | fibroma | 3.6% |
| 269 | Fibromatosis | 3.6% |
| 270 | Osteoblastoma | 3.6% |
| 271 | Osteoma | 3.6% |
| 272 | Rhabdomyoma | 3.6% |
| 273 | Chondromatosis | 3.6% |
| 274 | Adenocarcinoma, Clear Cell | 3.6% |
| 275 | Cholangiocarcinoma | 3.6% |
| 276 | Cervical Intraepithelial Neoplasia | 3.6% |
| 277 | Hemangioblastoma | 3.6% |
| 278 | Leukemia, Myeloid, Chronic-Phase | 3.5% |
| 279 | Thrombocythemia, Essential | 3.5% |
| 280 | Hydatidiform Mole | 3.5% |
| 281 | Digestive System Neoplasms | 3.4% |
| 282 | Endocrine Gland Neoplasms | 3.4% |
| 283 | Eye Neoplasms | 3.4% |
| 284 | Nervous System Neoplasms | 3.4% |
| 285 | Vipoma | 3.3% |
| 286 | Bone neoplasms | 3.3% |
| 287 | Leukoplakia | 3.3% |
| 288 | Pancreatic Cyst | 3.3% |
| 289 | Skin Neoplasms | 3.3% |
| 290 | Barrett Esophagus | 3.3% |
| 291 | Breast Cyst | 3.3% |
| 292 | Actinic keratosis | 3.3% |
| 293 | Mediastinal Cyst | 3.3% |
| 294 | Neoplasm Invasiveness | 3.3% |
| 295 | Neoplasm Metastasis | 3.3% |
| 296 | Neoplasm Recurrence, Local | 3.3% |
| 297 | Parovarian Cyst | 3.3% |
| 298 | Pericardial Cyst | 3.3% |
| 299 | Thymic Cyst | 3.3% |
| 300 | Carcinogenesis | 3.3% |
| 301 | Myxoid cyst | 3.3% |
| 302 | Metastasis | 3.3% |
| 303 | Sturge-Weber Syndrome | 3.3% |
| 304 | Multiple Endocrine Neoplasia Type 1 | 3.3% |
| 305 | Gastrointestinal Stromal Tumors | 3.2% |
| 306 | Prolactinoma | 3.2% |
| 307 | Growth Hormone-Secreting Pituitary Adenoma | 3.2% |
| 308 | neurofibroma | 3.2% |
| 309 | Environmental Illness | 3.1% |
| 310 | Thrombasthenia | 3% |
| 311 | Antithrombin III Deficiency | 3% |
| 312 | Protein C Deficiency | 3% |
| 313 | Lupus Erythematosus, Systemic | 3% |
| 314 | Pregnancy Complications, Hematologic | 3% |
| 315 | Overlap syndrome | 3% |
| 316 | Fibromatosis, Aggressive | 3% |
| 317 | Fibromatosis, Abdominal | 3% |
| 318 | Klatskin Tumor | 3% |
| 319 | Polycythemia Vera | 3% |
| 320 | Addison Disease | 3% |
| 321 | Pemphigus | 3% |
| 322 | Autoimmune thyroiditis | 3% |
| 323 | Primary Adrenal Insufficiency | 3% |
| 324 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2.9% |
| 325 | Autoimmune hepatitis | 2.9% |
| 326 | Mastocytoma | 2.9% |
| 327 | Adenomatous Polyposis Coli | 2.9% |
| 328 | Liver Neoplasms, Experimental | 2.9% |
| 329 | Parathyroid Neoplasms | 2.9% |
| 330 | Peritoneal Neoplasms | 2.9% |
| 331 | Thyroid Neoplasm | 2.9% |
| 332 | Thyroid carcinoma | 2.9% |
| 333 | granulosa cell tumor | 2.9% |
| 334 | Carcinoma, Ovarian Epithelial | 2.9% |
| 335 | Lambert-Eaton Myasthenic Syndrome | 2.7% |
| 336 | Corpus Luteum Cyst | 2.7% |
| 337 | Ovarian Cysts | 2.7% |
| 338 | Wiskott-Aldrich Syndrome | 2.7% |
| 339 | Vitamin K Deficiency | 2.7% |
| 340 | insulinoma | 2.7% |
| 341 | Hydrops Fetalis | 2.6% |
| 342 | Thrombocytosis | 2.6% |
| 343 | Job Syndrome | 2.6% |
| 344 | Kernicterus | 2.6% |
| 345 | Afibrinogenemia | 2.5% |
| 346 | Factor VII Deficiency | 2.5% |
| 347 | Factor X Deficiency | 2.5% |
| 348 | Factor XII Deficiency | 2.5% |
| 349 | Hemophilia A | 2.5% |
| 350 | Activated Protein C Resistance | 2.5% |
| 351 | Factor II deficiency | 2.5% |
| 352 | Factor VIII Deficiency | 2.5% |
| 353 | Factor V deficiency | 2.5% |
| 354 | Factor XI Deficiency | 2.5% |
| 355 | Hypoprothrombinemias | 2.5% |
| 356 | Pancreatic Neoplasm | 2.5% |
| 357 | Latent Autoimmune Diabetes in Adults | 2.5% |
| 358 | Dermatitis Herpetiformis | 2.5% |
| 359 | Kounis Syndrome | 2.5% |
| 360 | HIV Infections | 2.5% |
| 361 | Eosinophilic Granuloma | 2.4% |
| 362 | Splenosis | 2.4% |
| 363 | Retroperitoneal Neoplasms | 2.4% |
| 364 | Adrenocortical carcinoma | 2.4% |
| 365 | Gastrinoma | 2.4% |
| 366 | Glucagonoma | 2.4% |
| 367 | Choledochal Cyst | 2.4% |
| 368 | Tracheal Neoplasms | 2.4% |
| 369 | Peutz-Jeghers Syndrome | 2.3% |
| 370 | Leukoplakia, Oral | 2.3% |
| 371 | Nasopharyngeal carcinoma | 2.3% |
| 372 | Paraneoplastic Cerebellar Degeneration | 2.3% |
| 373 | Leydig Cell Tumor | 2.3% |
| 374 | Denys-Drash Syndrome | 2.2% |
| 375 | Chronic granulomatous disease | 2.2% |
| 376 | Rheumatoid Arthritis | 2.1% |
| 377 | Juvenile arthritis | 2.1% |
| 378 | Renal Cell Carcinoma | 2.1% |
| 379 | Papillary Renal Cell Carcinoma | 2.1% |
| 380 | Graves Disease | 2.1% |
| 381 | Anti-Glomerular Basement Membrane Disease | 2.1% |
| 382 | Asthma, Aspirin-Induced | 2% |
| 383 | Dupuytren Contracture | 2% |
| 384 | Esophageal Neoplasms | 2% |
| 385 | Carcinoma, Endometrioid | 2% |
| 386 | Limbic Encephalitis | 2% |
| 387 | anaphylaxis | 2% |
| 388 | Anemia, Hemolytic | 2% |
| 389 | Anemia, Macrocytic | 2% |
| 390 | Eosinophilia | 2% |
| 391 | Food Allergy | 2% |
| 392 | Hypoproteinemia | 2% |
| 393 | Leukopenia | 2% |
| 394 | Thrombocytopenia | 2% |
| 395 | Leukostasis | 2% |
| 396 | MYELODYSPLASTIC SYNDROME | 2% |
| 397 | Anaphylactic shock | 2% |
| 398 | Urticaria Pigmentosa | 2% |
| 399 | Mouth Neoplasms | 2% |
| 400 | Central Nervous System Neoplasms | 2% |
| 401 | Vascular Neoplasms | 2% |
| 402 | Genital Neoplasms, Female | 1.9% |
| 403 | Pancreatic Pseudocyst | 1.9% |
| 404 | Lymphatic Metastasis | 1.9% |
| 405 | Neoplasms, Unknown Primary | 1.9% |
| 406 | Leukemic Infiltration | 1.9% |
| 407 | Breast Neoplasms, Male | 1.9% |
| 408 | Neoplasm Micrometastasis | 1.9% |
| 409 | Triple Negative Breast Neoplasms | 1.9% |
| 410 | Hemoglobinuria, Paroxysmal | 1.9% |
| 411 | Leukemoid Reaction | 1.9% |
| 412 | Myelitis, Transverse | 1.9% |
| 413 | Thyroid Nodule | 1.9% |
| 414 | Serum Sickness | 1.8% |
| 415 | Testicular Neoplasms | 1.8% |
| 416 | Purpura, Thrombotic Thrombocytopenic | 1.7% |
| 417 | Respiratory Hypersensitivity | 1.7% |
| 418 | Adrenal Gland Neoplasms | 1.7% |
| 419 | Gastrointestinal Neoplasms | 1.7% |
| 420 | Genital Neoplasms, Male | 1.7% |
| 421 | Liver neoplasms | 1.7% |
| 422 | Uveal Neoplasms | 1.7% |
| 423 | Urologic Neoplasms | 1.6% |
| 424 | Anemia, Neonatal | 1.6% |
| 425 | Leukocytosis | 1.6% |
| 426 | Pelger-Huet Anomaly | 1.6% |
| 427 | Sick Building Syndrome | 1.6% |
| 428 | Pleocytosis | 1.6% |
| 429 | Multiple Chemical Sensitivity | 1.6% |
| 430 | Opsoclonus-Myoclonus Syndrome | 1.6% |
| 431 | Sebaceous Gland Neoplasms | 1.6% |
| 432 | Spinal Neoplasms | 1.6% |
| 433 | Anemia, Sickle Cell | 1.6% |
| 434 | Thalassemia | 1.6% |
| 435 | Urticaria | 1.6% |
| 436 | Vasculitis, Leukocytoclastic, Cutaneous | 1.6% |
| 437 | HTLV-I Infections | 1.6% |
| 438 | Polycystic Ovary Syndrome | 1.6% |
| 439 | Anemia, Diamond-Blackfan | 1.6% |
| 440 | Xeroderma Pigmentosum | 1.5% |
| 441 | Ataxia Telangiectasia | 1.5% |
| 442 | Myasthenia Gravis | 1.4% |
| 443 | Uveomeningoencephalitic Syndrome | 1.4% |
| 444 | Drug Eruptions | 1.4% |
| 445 | Ecchymosis | 1.4% |
| 446 | Petechiae | 1.4% |
| 447 | Purpura | 1.4% |
| 448 | Granulomatosis with polyangiitis | 1.3% |
| 449 | Dermatitis, Allergic Contact | 1.3% |
| 450 | HIV Seropositivity | 1.3% |
| 451 | Nose Neoplasms | 1.3% |
| 452 | Meningeal Neoplasms | 1.3% |
| 453 | Palatal Neoplasms | 1.3% |
| 454 | ovarian neoplasm | 1.2% |
| 455 | Pituitary Adenoma | 1.2% |
| 456 | Pituitary Neoplasms | 1.2% |
| 457 | Purpura, Hyperglobulinemic | 1.2% |
| 458 | Primary Myelofibrosis | 1.2% |
| 459 | Agranulocytosis | 1.2% |
| 460 | Anemia, Megaloblastic | 1.2% |
| 461 | Lymphocytosis | 1.2% |
| 462 | Myelofibrosis | 1.2% |
| 463 | Myeloid Metaplasia | 1.2% |
| 464 | Milk Allergy | 1.2% |
| 465 | Hypoalbuminemia | 1.2% |
| 466 | Wheat Hypersensitivity | 1.2% |
| 467 | Hypereosinophilic syndrome | 1.2% |
| 468 | bone marrow fibrosis | 1.2% |
| 469 | Thrombotic Microangiopathies | 1.2% |
| 470 | Stiff-Person Syndrome | 1.2% |
| 471 | Polyradiculoneuropathy | 1.2% |
| 472 | Polyradiculoneuritis | 1.2% |
| 473 | Acquired Immunodeficiency Syndrome | 1.2% |
| 474 | AIDS related complex | 1.2% |
| 475 | Felty Syndrome | 1.2% |
| 476 | Lupus Nephritis | 1.2% |
| 477 | Hemolytic-Uremic Syndrome | 1.1% |
| 478 | Ear Neoplasms | 1.1% |
| 479 | Eyelid Neoplasms | 1.1% |
| 480 | Lung Neoplasms | 1.1% |
| 481 | Pleural Neoplasms | 1.1% |
| 482 | Cell Transformation, Viral | 1.1% |
| 483 | Brain Neoplasms | 1.1% |
| 484 | Salivary Gland Neoplasms | 1.1% |
| 485 | Spinal Cord Neoplasms | 1.1% |
| 486 | Tongue Neoplasms | 1.1% |
| 487 | Myasthenia Gravis, Autoimmune, Experimental | 1.1% |
| 488 | Waterhouse-Friderichsen Syndrome | 1.1% |
| 489 | Uterine Neoplasms | 1.1% |
| 490 | Vaginal Neoplasms | 1.1% |
| 491 | Vulvar Neoplasms | 1.1% |
| 492 | Uterine Cancer | 1.1% |
| 493 | Fallopian Tube Neoplasms | 1.1% |
| 494 | AIDS-Related Opportunistic Infections | 1% |
| 495 | Vasculitis, Central Nervous System | 1% |
| 496 | Sickle Cell Trait | 1% |
| 497 | Dermatitis, Atopic | 1% |
| 498 | HIV Wasting Syndrome | 1% |
| 499 | Rheumatoid Vasculitis | 1% |
| 500 | AIDS Dementia Complex | 1% |
| 501 | AIDS-Associated Nephropathy | 1% |
| 502 | Zollinger-Ellison syndrome | 1% |
| 503 | Meningeal Carcinomatosis | 1% |
| 504 | Pharyngeal Neoplasms | 1% |
| 505 | Central Nervous System Cysts | 0.9% |
| 506 | Bile Duct Neoplasms | 0.9% |
| 507 | gallbladder neoplasm | 0.9% |
| 508 | Intestinal Neoplasms | 0.9% |
| 509 | Penile Neoplasms | 0.9% |
| 510 | Prostatic Neoplasms | 0.9% |
| 511 | Stomach Neoplasms | 0.9% |
| 512 | Lupus Vasculitis, Central Nervous System | 0.9% |
| 513 | Fanconi Anemia | 0.9% |
| 514 | Sicca Syndrome | 0.9% |
| 515 | Sjogren's Syndrome | 0.9% |
| 516 | HIV-Associated Lipodystrophy Syndrome | 0.9% |
| 517 | Laryngeal neoplasm | 0.8% |
| 518 | Eosinophilia-Myalgia Syndrome | 0.8% |
| 519 | Acute Chest Syndrome | 0.8% |
| 520 | Bronchial Neoplasms | 0.8% |
| 521 | Angioedema | 0.8% |
| 522 | Multiple Sclerosis | 0.8% |
| 523 | Shwartzman Phenomenon | 0.8% |
| 524 | Bladder Neoplasm | 0.8% |
| 525 | Kidney Neoplasm | 0.8% |
| 526 | Ureteral Neoplasms | 0.8% |
| 527 | Urethral Neoplasms | 0.8% |
| 528 | Multiple Pulmonary Nodules | 0.8% |
| 529 | Scurvy | 0.8% |
| 530 | Purpura Fulminans | 0.8% |
| 531 | Acute Generalized Exanthematous Pustulosis | 0.8% |
| 532 | Supratentorial Neoplasms | 0.8% |
| 533 | Neutropenia | 0.8% |
| 534 | Endometrial Neoplasms | 0.8% |
| 535 | Atypical Hemolytic Uremic Syndrome | 0.8% |
| 536 | Neuromyelitis Optica | 0.7% |
| 537 | Leukoencephalitis, Acute Hemorrhagic | 0.7% |
| 538 | Niemann-Pick Disease, Type C | 0.7% |
| 539 | Asthma | 0.7% |
| 540 | Hypopharyngeal Neoplasms | 0.7% |
| 541 | Pleural Effusion, Malignant | 0.7% |
| 542 | Hypopharyngeal Cancer | 0.7% |
| 543 | Encephalomyelitis, Acute Disseminated | 0.7% |
| 544 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 0.7% |
| 545 | Erythema Nodosum | 0.7% |
| 546 | Neuritis, Autoimmune, Experimental | 0.7% |
| 547 | Dermatitis, Photoallergic | 0.7% |
| 548 | Parotid Neoplasms | 0.7% |
| 549 | Prostatic Neoplasms, Castration-Resistant | 0.7% |
| 550 | Nelson Syndrome | 0.7% |
| 551 | Brain Stem Neoplasms | 0.7% |
| 552 | Pulmonary Eosinophilia | 0.7% |
| 553 | Eosinophilic Pneumonia | 0.7% |
| 554 | Anemia, Pernicious | 0.6% |
| 555 | Aspergillosis, Allergic Bronchopulmonary | 0.6% |
| 556 | Guillain-Barre Syndrome | 0.6% |
| 557 | Cecal Neoplasms | 0.6% |
| 558 | Duodenal Neoplasms | 0.6% |
| 559 | Febrile Neutropenia | 0.6% |
| 560 | Choroid Plexus Papilloma | 0.6% |
| 561 | Tonsillar Neoplasms | 0.6% |
| 562 | Cerebellar Neoplasms | 0.6% |
| 563 | Nasopharyngeal Neoplasms | 0.5% |
| 564 | Asthma, Exercise-Induced | 0.5% |
| 565 | Status Asthmaticus | 0.5% |
| 566 | Toxic Epidermal Necrolysis | 0.5% |
| 567 | Stevens-Johnson Syndrome | 0.5% |
| 568 | Colorectal Neoplasms | 0.5% |
| 569 | Multiple Sclerosis, Chronic Progressive | 0.5% |
| 570 | Multiple Sclerosis, Relapsing-Remitting | 0.5% |
| 571 | Radicular Cyst | 0.5% |
| 572 | Appendiceal Neoplasms | 0.5% |
| 573 | Colonic Neoplasms | 0.5% |
| 574 | Rectal Neoplasms | 0.5% |
| 575 | Pseudoxanthoma Elasticum | 0.5% |
| 576 | Paranasal Sinus Neoplasms | 0.5% |
| 577 | Giant Cell Arteritis | 0.5% |
| 578 | Temporal Arteritis | 0.5% |
| 579 | Asthma, Occupational | 0.5% |
| 580 | Farmer's Lung | 0.5% |
| 581 | Angioedemas, Hereditary | 0.5% |
| 582 | Hay fever | 0.5% |
| 583 | Rhinitis, Allergic, Perennial | 0.5% |
| 584 | Maxillary Sinus Neoplasms | 0.4% |
| 585 | Hereditary Angioedema Type III | 0.4% |
| 586 | Hereditary Angioedema Types I and II | 0.4% |
| 587 | Anus Neoplasms | 0.4% |
| 588 | Sigmoid Neoplasms | 0.4% |
| 589 | Miller Fisher Syndrome | 0.3% |